Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic
Go back to Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic| (NASDAQ: DRTS) | Delayed: 15.24 -0.25 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.49 | 52 Week High | $ | |||
| Open | $15.60 | 52 Week Low | $ | |||
| Day High | $15.63 | P/E | N/A | |||
| Day Low | $15.10 | EPS | $ | |||
| Volume | 624,260 | |||||
| (NASDAQ: DRTSW) | Delayed: 4.20 -0.17 (3.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.37 | 52 Week High | $ | |||
| Open | $4.31 | 52 Week Low | $ | |||
| Day High | $4.32 | P/E | N/A | |||
| Day Low | $4.15 | EPS | $ | |||
| Volume | 20,218 | |||||
